Tscan Therapeutics is trading 6.86% up now at $0.33 after opening amid a broad risk-on rebound.
- U.S. equities are gaining as falling oil prices ease inflation concerns.
- Technology and growth stocks lead the advance; Nasdaq futures were up 1.04% and S&P 500 futures 0.5% earlier Monday.
- No new company-specific announcement for September 21, 2026 was identified.